 Impaired lipopolysaccharide-inducible tumor necrosis factor production vitro peripheral blood monocytes patients viral hepatitis lipopolysaccharide-induced tumor necrosis factor production vitro peripheral blood monocytes patients various liver diseases Tumor necrosis factor production patients chronic hepatitis pg tumor necrosis factor/ml mean S.E.M patients chronic non-A non-B hepatitis pg tumor necrosis factor/ml healthy control individuals pg tumor necrosis factor/ml reduced tumor necrosis factor production optimal stimulating concentration lipopolysaccharide ng/ml suboptimal concentrations ng/ml contrast patients chronic viral hepatitis monocytes patients alcohol-induced cirrhosis pg tumor necrosis factor/ml primary biliary cirrhosis pg tumor necrosis factor/ml alcohol-induced fatty liver changes pg tumor necrosis factor/ml normal amounts tumor necrosis factor optimal concentration lipopolysaccharide Lipopolysaccharide lipopolysaccharide/ml peripheral blood monocytes patients chronic hepatitis pg/ml non-A non-B hepatitis pg/ml tumor necrosis factor gamma-interferon pg/ml pg/ml lymphokine monocytes cyclooxygenase inhibitor indomethacin suppressive effect prostaglandin pg/ml pg/ml